Study protocol of the multicentre, randomised, triple-blind, placebo-controlled MERCURI-2 trial: promoting effective renoprotection in cardiac surgery patients by inhibition of sodium glucose cotransporter (SGLT)-2.
Oosterom-Eijmael M, Monteiro de Oliveira NP, Niesten ED, Tolsma M, Snellen FT, Gerritse BM, Scohy TV, Rettig T, Godfried MB, Voogd MF, Wink J, van der Werff LM, Eberl S, Preckel B, Hermanides J, van Raalte DH, Hulst AH; MERCURI-2 study group.
Oosterom-Eijmael M, et al.
BMJ Open. 2025 May 16;15(5):e095504. doi: 10.1136/bmjopen-2024-095504.
BMJ Open. 2025.
PMID: 40379310
Free PMC article.